GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Marksans Pharma MARKSANS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

308.75

+1.66%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Marksans Pharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In INR.

FY2025FY2024FY2023FY2022FY2021
Revenue₹26.23bn₹21.77bn₹18.52bn₹14.91bn₹13.76bn
Operating income₹4.66bn₹3.88bn₹2.99bn₹2.14bn₹3.03bn
Net income₹3.81bn₹3.14bn₹2.66bn₹1.85bn₹2.36bn
Free cash flow₹337.4m₹215.7m₹1.84bn₹529.3m₹1.32bn
Total assets₹32.40bn—₹21.90bn₹16.40bn₹12.28bn
Shareholders' equity₹24.67bn—₹17.45bn₹12.02bn₹8.86bn

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.